‘Real-life’ experience with direct-acting antiviral agents for HCV after kidney transplant
Introductions and Objectives: The introduction of direct-acting antiviral (DAA) agents promises to change dramatically the management of hepatitis C in kidney transplant recipients, a patient group where the treatment of hepatitis C is historically challenging. The purpose of the current study was t...
Enregistré dans:
| Auteurs principaux: | , , , , , , , , , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Elsevier
2021
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/a10a721d539a4ef798649bedda9515fc |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|